U.S., May 10 -- ClinicalTrials.gov registry received information related to the study (NCT06963359) titled 'High-definition Surface Electromyography Markers for the Diagnosis and Monitoring of Sarcopenia' on Jan. 12, 2024.
Brief Summary: Sarcopenia is a progressive and generalised skeletal muscle disorder involving the accelerated loss of muscle mass and function that is associated with increased adverse outcomes including falls, functional decline, frailty, and mortality. In this project, the high-definition surface electromyography technology (HD-sEMG) signals will be analysed to extract features/ markers for the diagnosis of sarcopenia. This is a multicentric, descriptive, cross-sectional, parallel group study to develop a new diagnosti...